logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Mazen Noureddin

cedars sinai medical center

72H-index
546Paper Count
2.0WCitation Count
Published Papers 247
Publication Date
logo
Detection of Potential MetALD and ALD Using Phosphatidylethanol in a Large Multicenter MASH Trial Screening Cohort
errClinical Gastroenterology and Hepatology
IF12
err2026-08-25
err0
PREAI
errMazen Noureddin; Jörn M. Schattenberg; Rashmee Patil; Elizabeth W. Brombosz; Gražina Binkauskiene; Michelle Mazuranic; Laura Ladron de Guevara Cetina; Marcelo Kugelmas; Aasim Sheikh; John Poulos; Sudha Kodali; Brian P. Lee; Juan Pablo Arab; Naim Alkhouri
errShare
errSave
A decade of transformation in MASLD: from nomenclature to novel therapies
errLancet Gastroenterology & Hepatology
IF38.6
err2026-08-05
err0
PREAI
errJörn M Schattenberg; Mazen Noureddin
errShare
errSave
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
errLancet Gastroenterology & Hepatology
IF38.6
err2026-07-21
err0
PREAI
errMazen Noureddin; Winston Dunn; Rashmee Patil; Dimple Desai; Rohit Puskoor; Jaehee Shin; Dennis To; Adam C Bell; Daniel R Lee; Yen-Huei Lin; Seulki Lee
errShare
errSave
Loss of fungal sensing exacerbates liver injury in a murine model of MASLD
errJCI Insight
IF6.1
err2026-04-22
err0
PREAI
errPandyarajan, Vijay; Kim, So Yeon; Tsuchiya, Takashi; Liu, Selena; Bhat, Sadam H.; Kim, Jieun; Underhill, David M.; Noureddin, Mazen; Lu, Shelly C.; Seki, Ekihiro
errShare
errSave
Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Cirrhosis Clinical Trials: Lessons Learned and Future Directions
errDrugs
IF14.4
err2026-03-14
err0
PREAI
errRashmee Patil; Winston Dunn; Mazen Noureddin; Naim Alkhouri
errShare
errSave
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities
errAnnals of Hepatology
IF4.4
err2026-03-11
err0
errOAAI
errJeffrey V. Lazarus; Trenton M. White; Melina Manolas; Alina M. Allen; Silvana Pannain; Naim Alkhouri; Meena B. Bansal; Michael Charlton; Brett E. Fortune; Yehuda Handelsman; Scott D. Isaacs; Ira M. Jacobson; Sonal Kumar; Mazen Noureddin; Mary E. Rinella; Norah Terrault; Ayman El-Mohandes
errShare
errSave
Incretin-based therapies for cardio-kidney-liver-metabolic disease: the role of the liver in the modern era of chronic disease management
errClinical and Molecular Hepatology
IF16.9
err2026-01-01
err0
errOAAI
errElangovan, Harendran; Loomba, Rohit; Muthiah, Mark; Schattenberg, Joern; Zheng, Ming Hua; Noureddin, Mazen; Mantzoros, Christos; George, Jacob
errShare
errSave
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis
errClinical Gastroenterology and Hepatology
IF12
err2025-12-06
err0
PREAI
errArun J. Sanyal; Atsushi Nakajima; Elisabetta Bugianesi; Giada Sebastiani; Jörn M. Schattenberg; Leon A. Adams; Mazen Noureddin; Masato Yoneda; Pierre Bedossa; Zobair M. Younossi; Assim A. Alfadda; Andreas Geier; Frank Tacke; Giulio Marchesini; Giovanni Targher; Hussain Abdulrahman Al-Omar; Hannes Hagström; Juan G. Abraldes; Jerome Boursier; Kento Imajo
errShare
errSave
Research and clinical trial design in patients with metabolic dysfunction and alcohol-associated steatotic liver disease (MetALD): a narrative review
errMETABOLISM AND TARGET ORGAN DAMAGE
IF3.9
err2025-12-01
err0
PREAI
errAcuna, Pedro; Albhaisi, Omar; Idalsoaga, Francisco; Alkhouri, Naim; Noureddin, Mazen; Diaz, Luis Antonio; Arab, Juan Pablo
errShare
errSave
Waitlist and Post-Transplant Outcomes in Liver Transplantation for Alcohol-Associated Liver Disease: An Individual Patient Data Meta-Analysis
errAlimentary Pharmacology & Therapeutics
IF6.7
err2025-10-31
err0
PREAI
errGlenn Jun Kit Ho; Mirudhula Gnanavelou; Ryan Yanzhe Lim; Lucas Yang Yuxu Yeo; Benjamin Nah; Bryant Low; Talia Yi Hui Chan; Thanawin Pramotedham; Shi Yan Lee; Caleb Wei Hao Ng; Toru Nakamura; Hideki Fujii; Hirokazu Takahashi; Vincent L. Chen; Mazen Noureddin; Mark Muthiah; Wen Hui Lim; Mohammad Shadab Siddiqui; Eunice Xiang-Xuan Tan
errShare
errSave
Impact of MELD 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates
errClinical Gastroenterology and Hepatology
IF12
err2025-10-25
err0
PREAI
errWen Hui Lim; Darren Jun Hao Tan; Kartik Mitra; Margaret L.P. Teng; Cheng Han Ng; Donghyun Ko; Nicholas Syn; Alfred Wei-Chieh Kow; Daniel Tung; Atsushi Nakajima; Yoshio Sumida; Hirokazu Takahashi; Eunice X.X. Tan; Mazen Noureddin; Vincent L. Chen; Karn Wijarnpreecha; Daniel Q. Huang; Anh T. Bui; Mark Muthiah; Mohammad Shadab Siddiqui
errShare
errSave
Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial
errAlimentary Pharmacology & Therapeutics
IF6.7
err2025-10-23
err0
errOAAI
errMazen Noureddin; Mary Rinella; Rebecca Taub; Dominic Labriola; Raul C. Camacho; Naim Alkhouri; Rohit Loomba; Meena B. Bansal
errShare
errSave
Reply to Comments for ‘Appraisal of AI-Based Fibrosis Quantification in MASH’
errLiver International
IF5.2
err2025-09-20
err0
PREAI
errKutbuddin Akbary; Mazen Noureddin; Ren Yayun; Dean Tai; Pol Boudes
errShare
errSave
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis
errClinical Gastroenterology and Hepatology
IF12
err2025-09-09
err0
PREAI
errRyan Yanzhe Lim; Faith Xin Ning Tan; Glenn Jun Kit Ho; Ethan Kai Jun Tham; Alfred Kow; Guoyue Lv; Zhong-Qi Fan; Nicholas Syn; Masahito Nakano; Wenhao Li; Karn Wijarnpreecha; Jörn M. Schattenberg; Vincent Chen; Ming-Hua Zheng; Pojsakorn Danpanichkul; Hirokazu Takahashi; Cheng Han Ng; Yoshio Sumida; Atsushi Nakajima; Mazen Noureddin; Mark D. Muthiah; Daniel Q. Huang
errShare
errSave
Effect of varenicline on major adverse liver outcomes in alcohol-associated liver disease: An exploratory analysis
errALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH
IF2.7
err2025-09-01
err0
errOAAI
errDanpanichkul, Pojsakorn; Pang, Yanfang; Kim, Donghee; Suenghataiphorn, Thanathip; Ko, Donghyun; Ibrahim, Andrew F.; Prasitsumrit, Vitchapong; Duangsonk, Kwanjit; Noureddin, Mazen; Wijarnpreecha, Karn; Liangpunsakul, Suthat
errShare
errSave
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
errlancet
IF0
err2025-08-14
err0
PREAI
errMazen Noureddin; Juan P Frias; Guy W Neff; K Jean Lucas; Cynthia Behling; Pierre Bedossa; Julie Dubourg; Doreen Chan; Mark Burch; Erica Fong; Brittany de Temple; Matt Minerva; Kim Barrett; Reshma Shringarpure; Erik J Tillman; Timothy Rolph; Andrew Cheng; Kitty Yale
errShare
errSave
Development of AI Based Fibrosis Detection Algorithm by SHG/TPEF Microscopy for Fully Quantified Liver Fibrosis Assessment in MASH
errLiver International
IF5.2
err2025-08-04
err0
errOAAI
errKutbuddin Akbary; Mazen Noureddin; Ren Yayun; Dean Tai; Pol Boudes
errShare
errSave
In Reply: Health Inequalities of Early-Onset Gastrointestinal Cancers From 2000 to 2021: Findings Based on the Global Burden of Disease Study 2021
errMayo Clinic Proceedings
IF6.7
err2025-08-01
err0
PREAI
errPojsakorn Danpanichkul; Krittameth Rakwong; Mazen Noureddin; Donghee Kim; Denise M. Harnois; Ju Dong Yang; Michael B. Wallace; Karn Wijarnpreecha
errShare
errSave
Comparative Efficacy of Treatment Regimens for Chronic Hepatitis D Virus Infection: A Systematic Review and Network Meta-Analysis
errLiver International
IF5.2
err2025-07-16
err0
PREAI
errKonstantinos Ouranos; Evangelia K. Mylona; Charilaos Dellis; Dimitra Rafailia Bakaloudi; Fadi Shehadeh; Mazen Noureddin; Markos Kalligeros; Eleftherios Mylonakis
errShare
errSave
Determining Cirrhosis Status in Candidates for Resmetirom
errClinical Gastroenterology and Hepatology
IF12
err2025-05-10
err0
PREAI
errMazen Noureddin; Meena Bansal; Mary E. Rinella
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
M. Hassan Murad
H-index: 184 · Papers: 1.4K
A
Arun J. Sanyal
H-index: 166 · Papers: 1.4K
G
Gregory J. Gores
H-index: 164 · Papers: 1.0K
P
Patrick M. Bossuyt
H-index: 160 · Papers: 1.2K
R
Rohit Loomba
H-index: 154 · Papers: 1.3K
View more